G613

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 208244

CAS#: unknown

Description: G613 has shown growth inhibitory activity in breast cancer cells. Additionally, the compound decreased estrogen receptor activity through sequestration of estrogen receptor α by p53 thereby causing a decreased transcriptional activation and expression of proliferation markers. In conclusion, G613 represents a potent small-molecule inhibitor of the Mdm2-p53 interaction and can serve as a promising lead for developing a new class of anti-cancer therapy for breast cancer patients.


Chemical Structure

img
G613
CAS# unknown

Theoretical Analysis

MedKoo Cat#: 208244
Name: G613
CAS#: unknown
Chemical Formula: C36H34ClN3O4
Exact Mass: 607.22
Molecular Weight: 607.140
Elemental Analysis: C, 71.10; H, 5.64; Cl, 5.83; N, 6.91; O, 10.52

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: G-613, G6-13, G61-3

IUPAC/Chemical Name: 5-Chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one

InChi Key: QPWWUAQNASGKKV-LABVJWKOSA-N

InChi Code: InChI=1S/C36H34ClN3O4/c37-27-13-16-29-30(23-27)38-35(42)36(29)32(31(24-7-3-1-4-8-24)33(39-36)25-9-5-2-6-10-25)34(41)26-11-14-28(15-12-26)44-22-19-40-17-20-43-21-18-40/h1-16,23,31-33,39H,17-22H2,(H,38,42)/t31-,32+,33+,36-/m0/s1

SMILES Code: O=C1NC2=C([C@]31N[C@H](C4=CC=CC=C4)[C@@H](C5=CC=CC=C5)[C@@H]3C(C6=CC=C(OCCN7CCOCC7)C=C6)=O)C=CC(Cl)=C2

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 607.14 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Saxena R, Gupta G, Manohar M, Debnath U, Popli P, Prabhakar YS, Konwar R, Kumar S, Kumar A, Dwivedi A. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function. Int J Biochem Cell Biol. 2016 Jan;70:105-17. doi: 10.1016/j.biocel.2015.11.003. Epub 2015 Nov 7. PMID: 26556313.

2: Krüger L, Pridgen TA, Taylor ER, Garman KS, Blikslager AT. Lubiprostone protects esophageal mucosa from acid injury in porcine esophagus. Am J Physiol Gastrointest Liver Physiol. 2020 Apr 1;318(4):G613-G623. doi: 10.1152/ajpgi.00086.2019. Epub 2020 Feb 18. PMID: 32068440; PMCID: PMC7191458.

3: Floccari LV, Jeans KA, Herring JA, Johnston CE, Karol LA. Comparison of Outcomes by Reconstructive Strategy in Patients with Prostheses for Proximal Femoral Focal Deficiency. J Bone Joint Surg Am. 2021 Oct 6;103(19):1817-1825. doi: 10.2106/JBJS.20.02001. PMID: 34270496.

4: Van Klinken BJ, Dekker J, Büller HA, Einerhand AW. Mucin gene structure and expression: protection vs. adhesion. Am J Physiol. 1995 Nov;269(5 Pt 1):G613-27. doi: 10.1152/ajpgi.1995.269.5.G613. PMID: 7491952.

5: Mao Y, Zhang Z, Wong B. Use of green fluorescent protein fusions to analyse the N- and C-terminal signal peptides of GPI-anchored cell wall proteins in Candida albicans. Mol Microbiol. 2003 Dec;50(5):1617-28. doi: 10.1046/j.1365-2958.2003.03794.x. PMID: 14651643.

6: Kizu T, Yoshida Y, Furuta K, Ogura S, Egawa M, Chatani N, Hamano M, Takemura T, Ezaki H, Kamada Y, Nishida K, Nakaoka Y, Kiso S, Takehara T. Loss of Gab1 adaptor protein in hepatocytes aggravates experimental liver fibrosis in mice. Am J Physiol Gastrointest Liver Physiol. 2015 Apr 1;308(7):G613-24. doi: 10.1152/ajpgi.00289.2014. Epub 2015 Jan 23. PMID: 25617348.

7: Meir M, Flemming S, Burkard N, Bergauer L, Metzger M, Germer CT, Schlegel N. Glial cell line-derived neurotrophic factor promotes barrier maturation and wound healing in intestinal epithelial cells in vitro. Am J Physiol Gastrointest Liver Physiol. 2015 Oct 15;309(8):G613-24. doi: 10.1152/ajpgi.00357.2014. Epub 2015 Aug 20. PMID: 26294673.

8: Otte JM, Podolsky DK. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol. 2004 Apr;286(4):G613-26. doi: 10.1152/ajpgi.00341.2003. PMID: 15010363.

9: Donadio-Moura J, Gouw-Soares S, de Freitas PM, Navarro RS, Powell LG, Eduardo Cde P. Tensile bond strength of a flowable composite resin to ER:YAG-laser- treated dentin. Lasers Surg Med. 2005 Jun;36(5):351-5. doi: 10.1002/lsm.20176. PMID: 15825207.

10: Ewart WR, Wingate DL. Cholecystokinin octapeptide and gastric mechanoreceptor activity in rat brain. Am J Physiol. 1983 Jun;244(6):G613-7. doi: 10.1152/ajpgi.1983.244.6.G613. PMID: 6305211.